Related Experiment Video

Updated: Jun 12, 2026

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein

Pauline Isakson1, Magnar Bjørås, Stig Ove Bøe

  • 1Department of Biochemistry, Institute of Basic Medical Sciences, University of Oslo, Blindern, Oslo, Norway.

Blood
|June 25, 2010
PubMed

Insights

All-trans retinoic acid and arsenic trioxide induce autophagy, a cellular degradation process, in acute promyelocytic leukemia (APL) cells. This autophagy plays a key role in degrading the PML/RARA oncoprotein, crucial for APL treatment.

Area of Science:

  • Cellular Biology
  • Oncology
  • Molecular Medicine

Background:

  • Acute promyelocytic leukemia (APL) treatment with all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) targets the PML/RARA oncoprotein.
  • The ubiquitin-proteasome system was previously considered the primary mechanism for therapy-induced PML/RARA degradation.

Purpose of the Study:

  • To investigate the role of autophagy in the degradation of the PML/RARA oncoprotein during APL treatment.
  • To explore the relationship between autophagy and therapy-induced differentiation in APL cells.

Main Methods:

  • Induction of autophagy in APL cells using ATRA and ATO.
  • Assessment of PML/RARA degradation through autophagic and proteasomal pathways.
  • Correlation analysis between autophagy levels and APL cell differentiation.

Main Results:

  • Both ATRA and ATO induce autophagy in APL cells via the mammalian target of rapamycin (mTOR) pathway.
  • Autophagic degradation significantly contributes to both basal turnover and therapy-induced proteolysis of PML/RARA.
  • A correlation was observed between autophagy and therapy-induced differentiation of APL cells.

Conclusions:

  • Autophagy is a significant pathway involved in the degradation of the PML/RARA oncoprotein in APL.
  • Autophagy plays a crucial role in the mechanism of action of ATRA and ATO in APL treatment.
  • Targeting autophagy may represent a novel therapeutic strategy for APL.

More Related Videos

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...